ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

Why Retinitis Pigmentosa is on this study

  • ClinicalTrials.gov files the study under Retinitis Pigmentosa.
  • It is the study's main condition, by the main-condition rule: the study is compared with others under Retinitis Pigmentosa.
  • Rule based: the finest condition the study states.
6 links0 made here, not in the record10 judgments1 judge (the rules as one: Rule based)0 record changes seen
Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT05203939Study to Assess the Safetyand Efficacy of OCU400 forRetinitis Pigmentosa andLeber Congenital AmaurosisOcugenPhase 1/Phase 2 · active not rRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSRetinitis PigmentosaThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionLeber Congenital AmaurosisThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termNight Blindness, Congenital…The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termEnhanced S-Cone SyndromeThe registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termMeckel Syndrome, Type 4The registry's MeSH filing›Nov 14 · Rule based · Finest filed termFinest filed termDRUGSINT015379Entry “OCU400 Low Dose”, read by our …›As of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedAs of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
Nov 14Retinitis PigmentosaRule based · condition-kind ruleFinest filed termCurrent
Nov 14Leber Congenital AmaurosisRule based · condition-kind ruleFinest filed termCurrent
Nov 14Night Blindness, Congenital Stationary, Autosomal Dominant 1Rule based · condition-kind ruleFinest filed termCurrent
Nov 14Enhanced S-Cone SyndromeRule based · condition-kind ruleFinest filed termCurrent
Nov 14Meckel Syndrome, Type 4Rule based · condition-kind ruleFinest filed termCurrent
As of nowRetinitis PigmentosaRule based · main-condition ruleMain conditionCurrent
As of nowINT015379Rule based · role ruleTestedCurrent
As of nowINT015379Rule based · role ruleTestedCurrent
As of nowINT015379Rule based · role ruleTestedCurrent
As of nowINT015379Rule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.